European Patent Office

T 0597/92 (Rearrangement reaction) du 01.03.1995

Identifiant européen de la jurisprudence
ECLI:EP:BA:1995:T059792.19950301
Date de la décision
1 mars 1995
Numéro de l'affaire
T 0597/92
En ligne le
27 avril 1995
Requête en révision de
-
Numéro de la demande
81200211.1
Classe de la CIB
C07C 67/475
Langue de la procédure
Anglais
Distribution
Publiées au Journal officiel de l'OEB (A)
Téléchargement
-
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Process for preparing esters of 2-(6'-methoxy-2'-naphtyl)- propionic acid via rearrangement of new ketals of 2-halo-1-(6'- methoxy-2'-naphtyl)-propan-1-one
Nom du demandeur
BLASCHIM
Nom de l'opposant
Syntex Pharmaceuticals
Chambre
3.3.01
Sommaire

There is no basis in the EPC for the substantiation of inventive step by way of disclaimer. This method may only be used by way of exception for avoiding anticipation, if the subject-matter of a claim cannot be restricted on the basis of the original disclosure in positive terms without unduly impairing its clarity and conciseness.

A hypothetical novelty attack in possible proceedings before a national court, unsupported by pleadings or evidence on the file before the EPO, is not a sufficient reason under the EPC for allowing a disclaimer.

Mots-clés
Main request - disclaimer not allowed in the absence of concrete novelty attack
First auxiliary request - novelty (yes)
Inventive step (yes) - non-obvious solution
Exergue
-

ORDER

For these reasons it is decided that:

1. The opposition division's decision is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent on the basis of auxiliary request 1 with consequential amendments to the description, if necessary.